Opus Genetics (IRD) Long-Term Deferred Tax (2011 - 2014)
Opus Genetics (IRD) posted quarterly Long-Term Deferred Tax of $28.0 million for Q1 2014, up 13.31% year-over-year from $24.7 million in Q1 2013, and up 3.86% quarter-over-quarter from $26.9 million in Q4 2013.
Opus Genetics (IRD) Long-Term Deferred Tax (2011 - 2014) Analysis & Trends
Opus Genetics (IRD) has reported Long-Term Deferred Tax for 4 consecutive years, with $28.0 million the latest figure, recorded in Q1 2014.
- In Q1 2014, Long-Term Deferred Tax rose 13.31% year-over-year to $28.0 million; the TTM figure through Mar 2014 stood at $28.0 million (up 13.31% YoY), while the FY2013 annual figure was $26.9 million, up 11.74% from the prior year.
- Long-Term Deferred Tax improved to $28.0 million in Q1 2014 per IRD's latest filing, from $26.9 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $28.0 million in Q1 2014 and bottomed at $21.6 million in Q4 2011.
- Historically, Long-Term Deferred Tax has averaged $24.8 million across 4 years, with a median of $24.7 million in 2013.
- Annual changes were most pronounced in 2013 — Long-Term Deferred Tax climbed 10.23% — and 2014, when it grew 13.31%.
- Opus Genetics' Long-Term Deferred Tax stood at $21.6 million in 2011, then advanced by 11.53% to $24.1 million in 2012, then gained by 11.74% to $26.9 million in 2013, then rose by 3.86% to $28.0 million in 2014.
- Business Quant data shows IRD's Long-Term Deferred Tax at $28.0 million in Q1 2014, $26.9 million in Q4 2013, and $26.1 million in Q3 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Opus Genetics | 298.36 Mn | 209.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 27.96 Mn |
| Dec 31, 2013 | 26.92 Mn |
| Sep 30, 2013 | 26.09 Mn |
| Jun 30, 2013 | 25.39 Mn |
| Mar 31, 2013 | 24.68 Mn |
| Dec 31, 2012 | 24.09 Mn |
| Sep 30, 2012 | 23.67 Mn |
| Jun 30, 2012 | 23.00 Mn |
| Dec 31, 2011 | 21.60 Mn |